Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project.
de Leede EM, Sibinga Mulder BG, Bastiaannet E, Poston GJ, Sahora K, Van Eycken E, Valerianova Z, Mortensen MB, Dralle H, Primic-Žakelj M, Borràs JM, Gasslander T, Ryzhov A, Lemmens VE, Mieog JS, Boelens PG, van de Velde CJ, Bonsing BA. de Leede EM, et al. Eur J Surg Oncol. 2016 Sep;42(9):1414-9. doi: 10.1016/j.ejso.2016.03.011. Epub 2016 Mar 28. Eur J Surg Oncol. 2016. PMID: 27061790
Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study.
van Iersel LB, de Leede EM, Vahrmeijer AL, Tijl FG, den Hartigh J, Kuppen PJ, Hartgrink HH, Gelderblom H, Nortier JW, Tollenaar RA, van de Velde CJ. van Iersel LB, et al. Among authors: de leede em. Eur J Surg Oncol. 2014 Nov;40(11):1557-63. doi: 10.1016/j.ejso.2014.06.010. Epub 2014 Jul 25. Eur J Surg Oncol. 2014. PMID: 25125340 Clinical Trial.
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study.
Meijer TS, Burgmans MC, de Leede EM, de Geus-Oei LF, Boekestijn B, Handgraaf HJM, Hilling DE, Lutjeboer J, Vuijk J, Martini CH, van Erkel AR, van der Meer RW, Tijl FGJ, Speetjens FM, Kapiteijn E, Vahrmeijer AL. Meijer TS, et al. Among authors: de leede em. Ann Surg Oncol. 2021 Feb;28(2):1130-1141. doi: 10.1245/s10434-020-08741-x. Epub 2020 Aug 5. Ann Surg Oncol. 2021. PMID: 32761328 Free PMC article. Clinical Trial.
Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.
de Leede EM, Burgmans MC, Meijer TS, Martini CH, Tijl FGJ, Vuyk J, van Erkel AR, van der Velde CJH, Kapiteijn E, Vahrmeijer AL. de Leede EM, et al. Cardiovasc Intervent Radiol. 2017 Aug;40(8):1196-1205. doi: 10.1007/s00270-017-1630-4. Epub 2017 Apr 27. Cardiovasc Intervent Radiol. 2017. PMID: 28451811 Free PMC article. Clinical Trial.
Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial.
Meijer TS, Burgmans MC, Fiocco M, de Geus-Oei LF, Kapiteijn E, de Leede EM, Martini CH, van der Meer RW, Tijl FGJ, Vahrmeijer AL. Meijer TS, et al. Among authors: de leede em. Cardiovasc Intervent Radiol. 2019 Jun;42(6):841-852. doi: 10.1007/s00270-019-02177-x. Epub 2019 Feb 14. Cardiovasc Intervent Radiol. 2019. PMID: 30767147 Free PMC article. Clinical Trial.
Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
Meijer TS, Dieters JHN, de Leede EM, de Geus-Oei LF, Vuijk J, Martini CH, van Erkel AR, Lutjeboer J, van der Meer RW, Tijl FGJ, Kapiteijn E, Vahrmeijer AL, Burgmans MC. Meijer TS, et al. Among authors: de leede em. PLoS One. 2022 Jan 13;17(1):e0261939. doi: 10.1371/journal.pone.0261939. eCollection 2022. PLoS One. 2022. PMID: 35025911 Free PMC article.
14 results